Impact of Discordance Between Magnetic Resonance Imaging and Ultrasound Volume Measurements on Prostate Fusion Biopsy Outcomes

Although MRI/US-targeted fusion biopsy detected more prostate cancers than systematic biopsy, the performance of MRI/US-targeted fusion biopsy declined with more discordance between volumes measured in MRI vs US. Awareness of volume discordance in MRI- and US-based volume measurements should alert the operator about the possibility of reduced performance of MRI/US-targeted fusion biopsy.

Authors

Institutions

Publication Details

Journal
The Journal of Urology
Published
2025-03-07
DOI
https://doi.org/10.1097/ju.0000000000004368
Citations
3
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
4.56
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Discordance Between Magnetic Resonance Imaging and Ultrasound Volume Measurements on Prostate Fusion Biopsy Outcomes

Laetitia Saccenti, Sandeep Gurram, Barış Türkbey, Bradford J. Wood et al.
3 citations
The Journal of Urology
Prostate Cancer Diagnosis and Treatment
4.56
article

Impact of Discordance Between Magnetic Resonance Imaging and Ultrasound Volume Measurements on Prostate Fusion Biopsy Outcomes

Laetitia Saccenti, Sandeep Gurram, Barış Türkbey, Bradford J. Wood, Lindsey Hazen, Peter A. Pinto, Charisse Garcia, Tabea Borde, Nicole Varble, Maria Digennaro
article en
3 citations

Abstract

Although MRI/US-targeted fusion biopsy detected more prostate cancers than systematic biopsy, the performance of MRI/US-targeted fusion biopsy declined with more discordance between volumes measured in MRI vs US. Awareness of volume discordance in MRI- and US-based volume measurements should alert the operator about the possibility of reduced performance of MRI/US-targeted fusion biopsy.

The Journal of UrologyVol. 213(4)
National Institutes of Health (US), Inserm (FR), Philips (United States) (US), National Cancer Institute (US), National Institutes of Health Clinical Center (US), Institut Mondor de Recherche Biomédicale (FR)
Openalex Percentile: Top 7%
Prostate Cancer Diagnosis and Treatment
4.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.